Krystal Biotech, Inc. (KRYS) Operating margin 2023–2025
Krystal Biotech, Inc. (KRYS) operating margin by fiscal year — reported operating income divided by reported revenue.
41.5%FY2025 · since FY2023: -216.2% → 41.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 41.5% | +18.8 pp |
| FY2024 | 22.6% | +238.8 pp |
| FY2023 | -216.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice